Loading stock data…
SiNtx Technologies, Inc. (SINT)
$1.74+0.11 (+6.75%)
Market ClosedLast close Sep 8
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Sintx Technologies, Inc. in the Healthcare sector is trading at $1.74 with a market capitalization of $10M. Wall Street consensus targets $9.12 (4 analysts), implying a +424.4% move over the next 12 months. The stock is currently near its 52-week low of $1.40, remaining 32.6% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 25/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Sell-side targets imply +424.4% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $300,000↑ | $188,000↑ | $150,000↑ | $100,000↓ | $291,000 |
| Gross Profit | $64,000↓ | $86,000↑ | $35,000↑ | $6,000↓ | $45,000 |
| Operating Income | -$3.21M↓ | -$2.32M↑ | -$3.35M↓ | -$2.67M↓ | -$2.38M |
| Net Income | -$2.82M↓ | -$2.21M↑ | -$3.54M↓ | -$2.32M↓ | -$2.29M |
Peer Comparison
JNJUNHPFE
Fundamentals
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$9.68M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.61
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-1204.98%
Volume
Today's trading volume
30,330
Recent News
SINTX TECHNOLOGIES (SINT) Moves to Buy: Rationale Behind the Upgrade
SINTX TECHNOLOGIES (SINT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Sintx Technologies, Inc. Q2 2026 Earnings Call Summary
Moby summary of Sintx Technologies, Inc.'s Q2 2026 earnings call
SINTX Technologies Inc (SINT) (Q2 2026) Earnings Call Highlights: Revenue Surges 199% as ...
SINTX Technologies Inc (SINT) reports strong product revenue growth and improved margins, while managing liquidity challenges and advancing its SINAPTIC medical platform.
LivaNova (LIVN) Q2 Earnings and Revenues Beat Estimates
LivaNova (LIVN) delivered earnings and revenue surprises of +16.67% and +2.90%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates
ClearPoint Neuro (CLPT) delivered earnings and revenue surprises of -31.03% and -16.31%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?